A carregar...

Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases

BACKGROUND: Polypharmacy is associated with dyspnea in cross-sectional studies, but associations have not been determined in longitudinal analyses. Statins are commonly prescribed but their contribution to dyspnea is unknown. We determined whether polypharmacy was associated with dyspnea trajectory...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hosp Palliat Care
Main Authors: Akgün, Kathleen M., Krishnan, Supriya, Feder, Shelli L., Tate, Janet, Kutner, Jean S., Crothers, Kristina
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318598/
https://ncbi.nlm.nih.gov/pubmed/31550901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1049909119877512
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!